Evixapodlin
GS-US-494-5484
Phase 1 small_molecule terminated
Quick answer
Evixapodlin for Advanced Solid Tumors is a Phase 1 program (small_molecule) at Gilead Sciences Ireland UC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Gilead Sciences Ireland UC
- Indication
- Advanced Solid Tumors
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated